Rankings
▼
Calendar
ORGO Q4 2016 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$338M
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$61,084
Gross Profit
-$117,072
-191.7% margin
Operating Income
$178,156
291.7% margin
Net Income
-$178,156
-291.7% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$537,747
Free Cash Flow
-$537,747
Stock-Based Comp.
$304M
Balance Sheet
Total Assets
$311M
Total Liabilities
$11M
Stockholders' Equity
$300M
Cash & Equivalents
$1M
← FY 2016
All Quarters
Q1 2017 →
